

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of histone deacetylation (GO:0031065) | 4.15738691 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.08502656 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.08502656 |
| 4 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.79101731 |
| 5 | maternal placenta development (GO:0001893) | 3.77542685 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.63424917 |
| 7 | apoptotic cell clearance (GO:0043277) | 3.47250109 |
| 8 | protein localization to endosome (GO:0036010) | 3.38902972 |
| 9 | response to laminar fluid shear stress (GO:0034616) | 3.38690575 |
| 10 | response to muramyl dipeptide (GO:0032495) | 3.38078701 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 3.25921043 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 3.25921043 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.25921043 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.25921043 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.25921043 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 3.25921043 |
| 17 | low-density lipoprotein particle clearance (GO:0034383) | 3.24315161 |
| 18 | negative regulation of fatty acid transport (GO:2000192) | 3.21557950 |
| 19 | response to peptidoglycan (GO:0032494) | 3.20445511 |
| 20 | skin morphogenesis (GO:0043589) | 3.18520671 |
| 21 | negative regulation of cell size (GO:0045792) | 3.15009285 |
| 22 | endothelial cell chemotaxis (GO:0035767) | 3.14361582 |
| 23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.10108422 |
| 24 | mannose metabolic process (GO:0006013) | 3.05639418 |
| 25 | NIK/NF-kappaB signaling (GO:0038061) | 3.05622959 |
| 26 | positive regulation of p38MAPK cascade (GO:1900745) | 3.03453187 |
| 27 | regulation of cholesterol storage (GO:0010885) | 3.01376422 |
| 28 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.00816528 |
| 29 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.00201269 |
| 30 | modulation by symbiont of host cellular process (GO:0044068) | 2.98930077 |
| 31 | regulation of cholesterol homeostasis (GO:2000188) | 2.95496670 |
| 32 | regulation of p38MAPK cascade (GO:1900744) | 2.95340257 |
| 33 | positive regulation of protein deacetylation (GO:0090312) | 2.95165979 |
| 34 | cell-substrate junction assembly (GO:0007044) | 2.92509315 |
| 35 | regulation of extracellular matrix disassembly (GO:0010715) | 2.91215893 |
| 36 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.91160089 |
| 37 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.88703983 |
| 38 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.86568192 |
| 39 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.86438339 |
| 40 | embryonic process involved in female pregnancy (GO:0060136) | 2.85563362 |
| 41 | adherens junction assembly (GO:0034333) | 2.81933181 |
| 42 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.79875241 |
| 43 | regulation of necrotic cell death (GO:0010939) | 2.77102707 |
| 44 | detection of other organism (GO:0098543) | 2.74804610 |
| 45 | barbed-end actin filament capping (GO:0051016) | 2.72983089 |
| 46 | macrophage activation involved in immune response (GO:0002281) | 2.72375305 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.71616611 |
| 48 | endodermal cell differentiation (GO:0035987) | 2.70673507 |
| 49 | detection of bacterium (GO:0016045) | 2.70546873 |
| 50 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.69692169 |
| 51 | semaphorin-plexin signaling pathway (GO:0071526) | 2.68924921 |
| 52 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.68699690 |
| 53 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.66811203 |
| 54 | cell adhesion mediated by integrin (GO:0033627) | 2.66035544 |
| 55 | basement membrane organization (GO:0071711) | 2.65898425 |
| 56 | modulation by virus of host process (GO:0019054) | 2.65849528 |
| 57 | cortical actin cytoskeleton organization (GO:0030866) | 2.65683308 |
| 58 | regulation of gamma-delta T cell activation (GO:0046643) | 2.65437427 |
| 59 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.65192115 |
| 60 | focal adhesion assembly (GO:0048041) | 2.63514797 |
| 61 | cell-substrate adherens junction assembly (GO:0007045) | 2.63514797 |
| 62 | COPI coating of Golgi vesicle (GO:0048205) | 2.62804899 |
| 63 | Golgi transport vesicle coating (GO:0048200) | 2.62804899 |
| 64 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.61372233 |
| 65 | regulation of early endosome to late endosome transport (GO:2000641) | 2.61160569 |
| 66 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.60559348 |
| 67 | protein heterotrimerization (GO:0070208) | 2.59460930 |
| 68 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.59179627 |
| 69 | regulation of necroptotic process (GO:0060544) | 2.58170833 |
| 70 | response to fluid shear stress (GO:0034405) | 2.57443098 |
| 71 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.57279436 |
| 72 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.56475195 |
| 73 | negative regulation of necrotic cell death (GO:0060547) | 2.55090083 |
| 74 | 4-hydroxyproline metabolic process (GO:0019471) | 2.54728474 |
| 75 | negative regulation of lipid transport (GO:0032369) | 2.54263742 |
| 76 | positive regulation of nuclease activity (GO:0032075) | 2.53124461 |
| 77 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.52501124 |
| 78 | cellular response to virus (GO:0098586) | 2.50947574 |
| 79 | negative regulation of myotube differentiation (GO:0010832) | 2.50870334 |
| 80 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.50723257 |
| 81 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.50690072 |
| 82 | plasma membrane repair (GO:0001778) | 2.50667413 |
| 83 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.49856596 |
| 84 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.49028673 |
| 85 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.48902124 |
| 86 | stress fiber assembly (GO:0043149) | 2.48077655 |
| 87 | protein retention in ER lumen (GO:0006621) | 2.47553082 |
| 88 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.47328238 |
| 89 | negative regulation of necroptotic process (GO:0060546) | 2.47038983 |
| 90 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.46727731 |
| 91 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.44602508 |
| 92 | response to host (GO:0075136) | 2.44602508 |
| 93 | response to host defenses (GO:0052200) | 2.44602508 |
| 94 | detection of external biotic stimulus (GO:0098581) | 2.42957419 |
| 95 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.42715751 |
| 96 | positive thymic T cell selection (GO:0045059) | 2.42520703 |
| 97 | activation of Rac GTPase activity (GO:0032863) | 2.41912399 |
| 98 | germinal center formation (GO:0002467) | 2.41730343 |
| 99 | pentose-phosphate shunt (GO:0006098) | 2.41715269 |
| 100 | regulation of leukocyte degranulation (GO:0043300) | 2.41086591 |
| 101 | morphogenesis of an endothelium (GO:0003159) | 2.38988816 |
| 102 | endothelial tube morphogenesis (GO:0061154) | 2.38988816 |
| 103 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.38858649 |
| 104 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.38438586 |
| 105 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.38427157 |
| 106 | growth hormone receptor signaling pathway (GO:0060396) | 2.38177934 |
| 107 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.38177638 |
| 108 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.37205361 |
| 109 | negative regulation of interleukin-12 production (GO:0032695) | 2.36749980 |
| 110 | thymic T cell selection (GO:0045061) | 2.36709557 |
| 111 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.34507408 |
| 112 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.33836751 |
| 113 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.31588429 |
| 114 | detection of molecule of bacterial origin (GO:0032490) | 2.31427152 |
| 115 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.30360461 |
| 116 | natural killer cell differentiation (GO:0001779) | 2.29861358 |
| 117 | regulation of ARF protein signal transduction (GO:0032012) | 2.29775076 |
| 118 | regulation of extracellular matrix organization (GO:1903053) | 2.29243195 |
| 119 | positive regulation of myotube differentiation (GO:0010831) | 2.29108514 |
| 120 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.28247766 |
| 121 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.27596532 |
| 122 | response to host immune response (GO:0052572) | 2.27596532 |
| 123 | positive regulation of extracellular matrix organization (GO:1903055) | 2.27301490 |
| 124 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.26800742 |
| 125 | histone H3-K36 demethylation (GO:0070544) | 2.25681294 |
| 126 | coronary vasculature morphogenesis (GO:0060977) | 2.25476326 |
| 127 | negative regulation of viral release from host cell (GO:1902187) | 2.24957715 |
| 128 | regulation of nuclease activity (GO:0032069) | 2.24780143 |
| 129 | cellular response to unfolded protein (GO:0034620) | 2.22936783 |
| 130 | germ cell migration (GO:0008354) | 2.22019673 |
| 131 | ER-nucleus signaling pathway (GO:0006984) | 2.21271286 |
| 132 | detection of biotic stimulus (GO:0009595) | 2.19752963 |
| 133 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.19543372 |
| 134 | activation of MAPKKK activity (GO:0000185) | 2.19077445 |
| 135 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.18595115 |
| 136 | negative regulation of cell killing (GO:0031342) | 2.18595115 |
| 137 | leukocyte aggregation (GO:0070486) | 2.17813571 |
| 138 | cell-cell junction maintenance (GO:0045217) | 2.17747878 |
| 139 | valine metabolic process (GO:0006573) | 2.16661553 |
| 140 | protein carboxylation (GO:0018214) | 2.16534959 |
| 141 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.16534959 |
| 142 | negative regulation of fibrinolysis (GO:0051918) | 2.16346643 |
| 143 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.16197108 |
| 144 | negative regulation of granulocyte differentiation (GO:0030853) | 2.16015000 |
| 145 | cortical cytoskeleton organization (GO:0030865) | 2.15921315 |
| 146 | sulfur amino acid catabolic process (GO:0000098) | 2.14173778 |
| 147 | regulation of integrin activation (GO:0033623) | 2.14122249 |
| 148 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.11945424 |
| 149 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.11421395 |
| 150 | negative regulation of stress fiber assembly (GO:0051497) | 2.09332594 |
| 151 | mRNA stabilization (GO:0048255) | 2.09067564 |
| 152 | RNA stabilization (GO:0043489) | 2.09067564 |
| 153 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.08094638 |
| 154 | regulation of ARF GTPase activity (GO:0032312) | 2.07833333 |
| 155 | pinocytosis (GO:0006907) | 2.07224945 |
| 156 | negative regulation of innate immune response (GO:0045824) | 2.06898538 |
| 157 | negative regulation of bone resorption (GO:0045779) | 2.06743021 |
| 158 | epithelial cell-cell adhesion (GO:0090136) | 2.06646950 |
| 159 | blood vessel endothelial cell migration (GO:0043534) | 2.06373857 |
| 160 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.05753288 |
| 161 | activation of JUN kinase activity (GO:0007257) | 2.04935120 |
| 162 | substrate-dependent cell migration (GO:0006929) | 2.04143669 |
| 163 | cellular response to nutrient (GO:0031670) | 2.03916933 |
| 164 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.03068754 |
| 165 | receptor catabolic process (GO:0032801) | 2.02618614 |
| 166 | apoptotic process involved in morphogenesis (GO:0060561) | 2.02499083 |
| 167 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.02364684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.24485134 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.16054746 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 2.70960483 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.68886267 |
| 5 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.63336766 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.56191624 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.53960436 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.49059850 |
| 9 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.48324280 |
| 10 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.46279007 |
| 11 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.45175205 |
| 12 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.43985808 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.36836401 |
| 14 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.23021352 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.07650629 |
| 16 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03972065 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.03735654 |
| 18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.02411127 |
| 19 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.02343550 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.00709293 |
| 21 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.91613131 |
| 22 | * MAF_26560356_Chip-Seq_TH1_Human | 1.85847657 |
| 23 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.82232026 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.82006560 |
| 25 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.81718621 |
| 26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.81199474 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.79919192 |
| 28 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.79203607 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.78782625 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.78428321 |
| 31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77501033 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76229111 |
| 33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.74745534 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71426982 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.70250627 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.68930763 |
| 37 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.67774419 |
| 38 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.67244778 |
| 39 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.63071131 |
| 40 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.58598546 |
| 41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57476774 |
| 42 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.56273216 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55734843 |
| 44 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53571206 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52354636 |
| 46 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.51169592 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.49277636 |
| 48 | ATF3_27146783_Chip-Seq_COLON_Human | 1.49149217 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47363524 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47035046 |
| 51 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46016057 |
| 52 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.44497499 |
| 53 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.43020471 |
| 54 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.37434283 |
| 55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37269891 |
| 56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34394592 |
| 57 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34138795 |
| 58 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31127035 |
| 59 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30256973 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30135514 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29523874 |
| 62 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.28699344 |
| 63 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.28671736 |
| 64 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.28127749 |
| 65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28084396 |
| 66 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.27806940 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 1.27288799 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26610011 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26197736 |
| 70 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.25816270 |
| 71 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.25439906 |
| 72 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.25127906 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24312876 |
| 74 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23856805 |
| 75 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.23636946 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 1.23194755 |
| 77 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.22894243 |
| 78 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.22490571 |
| 79 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22421599 |
| 80 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21854725 |
| 81 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21661058 |
| 82 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20898976 |
| 83 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.19752927 |
| 84 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18103679 |
| 85 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16010454 |
| 86 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.14551483 |
| 87 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.13959074 |
| 88 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.12321720 |
| 89 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10948204 |
| 90 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09818649 |
| 91 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09439200 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08713963 |
| 93 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08278503 |
| 94 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.07735018 |
| 95 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.07082336 |
| 96 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.06822667 |
| 97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06707815 |
| 98 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.05764540 |
| 99 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05709045 |
| 100 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05433579 |
| 101 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05123494 |
| 102 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.03490659 |
| 103 | P68_20966046_ChIP-Seq_HELA_Human | 1.02874579 |
| 104 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02575504 |
| 105 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01711211 |
| 106 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01642796 |
| 107 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01476098 |
| 108 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01476098 |
| 109 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01378662 |
| 110 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01294375 |
| 111 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.01270020 |
| 112 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00316437 |
| 113 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.00090787 |
| 114 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.00066566 |
| 115 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.99969824 |
| 116 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99092949 |
| 117 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98207757 |
| 118 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97854830 |
| 119 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96944963 |
| 120 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.96583471 |
| 121 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.96141839 |
| 122 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95365259 |
| 123 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95183240 |
| 124 | * MYB_26560356_Chip-Seq_TH1_Human | 0.94863976 |
| 125 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.93298283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.16242089 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.41769253 |
| 3 | MP0005451_abnormal_body_composition | 3.16866024 |
| 4 | MP0003303_peritoneal_inflammation | 3.11569691 |
| 5 | MP0003300_gastrointestinal_ulcer | 2.81394355 |
| 6 | MP0003566_abnormal_cell_adhesion | 2.62778788 |
| 7 | MP0009278_abnormal_bone_marrow | 2.54310677 |
| 8 | MP0004510_myositis | 2.37833107 |
| 9 | MP0008260_abnormal_autophagy | 2.30846133 |
| 10 | MP0004858_abnormal_nervous_system | 2.16069623 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.10426007 |
| 12 | MP0005275_abnormal_skin_tensile | 2.09631264 |
| 13 | MP0009840_abnormal_foam_cell | 2.03823736 |
| 14 | MP0003279_aneurysm | 1.88634064 |
| 15 | MP0003436_decreased_susceptibility_to | 1.84216187 |
| 16 | MP0000685_abnormal_immune_system | 1.71560058 |
| 17 | MP0001958_emphysema | 1.64141606 |
| 18 | MP0000733_abnormal_muscle_development | 1.61095940 |
| 19 | MP0003763_abnormal_thymus_physiology | 1.60463317 |
| 20 | MP0005409_darkened_coat_color | 1.59208479 |
| 21 | MP0005076_abnormal_cell_differentiation | 1.59197911 |
| 22 | MP0005023_abnormal_wound_healing | 1.54656408 |
| 23 | MP0005058_abnormal_lysosome_morphology | 1.54488768 |
| 24 | MP0004947_skin_inflammation | 1.48689956 |
| 25 | MP0010368_abnormal_lymphatic_system | 1.46981269 |
| 26 | MP0010352_gastrointestinal_tract_polyps | 1.45031890 |
| 27 | MP0004185_abnormal_adipocyte_glucose | 1.44746189 |
| 28 | MP0002877_abnormal_melanocyte_morpholog | 1.44671516 |
| 29 | MP0003329_amyloid_beta_deposits | 1.44581284 |
| 30 | MP0005623_abnormal_meninges_morphology | 1.42807603 |
| 31 | MP0003453_abnormal_keratinocyte_physiol | 1.41740222 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 1.40226029 |
| 33 | MP0006054_spinal_hemorrhage | 1.38562789 |
| 34 | MP0002254_reproductive_system_inflammat | 1.38453076 |
| 35 | MP0001348_abnormal_lacrimal_gland | 1.37042822 |
| 36 | MP0003091_abnormal_cell_migration | 1.36616909 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.31880011 |
| 38 | MP0004130_abnormal_muscle_cell | 1.31660083 |
| 39 | MP0008961_abnormal_basal_metabolism | 1.31418884 |
| 40 | MP0003252_abnormal_bile_duct | 1.31103420 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.30255491 |
| 42 | MP0003045_fibrosis | 1.29714325 |
| 43 | MP0002139_abnormal_hepatobiliary_system | 1.27900673 |
| 44 | MP0002060_abnormal_skin_morphology | 1.26884817 |
| 45 | MP0006082_CNS_inflammation | 1.23538474 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.22931526 |
| 47 | MP0000767_abnormal_smooth_muscle | 1.20843875 |
| 48 | MP0003183_abnormal_peptide_metabolism | 1.19273284 |
| 49 | MP0005375_adipose_tissue_phenotype | 1.19237154 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.18010650 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.18010650 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.17993826 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.16249639 |
| 54 | MP0000604_amyloidosis | 1.15928367 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.12551247 |
| 56 | MP0000678_abnormal_parathyroid_gland | 1.11257389 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.10828484 |
| 58 | MP0004808_abnormal_hematopoietic_stem | 1.09751742 |
| 59 | MP0005360_urolithiasis | 1.09121658 |
| 60 | MP0001849_ear_inflammation | 1.07612400 |
| 61 | MP0000747_muscle_weakness | 1.06894928 |
| 62 | MP0010630_abnormal_cardiac_muscle | 1.06277238 |
| 63 | MP0004087_abnormal_muscle_fiber | 1.05808154 |
| 64 | MP0003828_pulmonary_edema | 1.05176191 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.04015026 |
| 66 | MP0002933_joint_inflammation | 1.03925382 |
| 67 | MP0001851_eye_inflammation | 1.03564237 |
| 68 | MP0000003_abnormal_adipose_tissue | 1.03148940 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.02997515 |
| 70 | MP0004272_abnormal_basement_membrane | 1.02710042 |
| 71 | MP0001790_abnormal_immune_system | 1.02188735 |
| 72 | MP0005387_immune_system_phenotype | 1.02188735 |
| 73 | MP0005083_abnormal_biliary_tract | 1.02120762 |
| 74 | MP0004233_abnormal_muscle_weight | 1.00709858 |
| 75 | MP0001879_abnormal_lymphatic_vessel | 0.99838783 |
| 76 | MP0000537_abnormal_urethra_morphology | 0.99563041 |
| 77 | MP0003172_abnormal_lysosome_physiology | 0.99558558 |
| 78 | MP0002166_altered_tumor_susceptibility | 0.99255871 |
| 79 | MP0005025_abnormal_response_to | 0.99154748 |
| 80 | MP0000343_altered_response_to | 0.98807271 |
| 81 | MP0002396_abnormal_hematopoietic_system | 0.96734454 |
| 82 | MP0000609_abnormal_liver_physiology | 0.96674264 |
| 83 | MP0001853_heart_inflammation | 0.96584480 |
| 84 | MP0003448_altered_tumor_morphology | 0.96409435 |
| 85 | MP0000716_abnormal_immune_system | 0.96193312 |
| 86 | MP0002398_abnormal_bone_marrow | 0.95861043 |
| 87 | MP0005621_abnormal_cell_physiology | 0.95127777 |
| 88 | MP0000751_myopathy | 0.94101621 |
| 89 | MP0000750_abnormal_muscle_regeneration | 0.92709508 |
| 90 | MP0000858_altered_metastatic_potential | 0.92600186 |
| 91 | MP0005000_abnormal_immune_tolerance | 0.92219826 |
| 92 | MP0000490_abnormal_crypts_of | 0.91596262 |
| 93 | MP0002148_abnormal_hypersensitivity_rea | 0.91507351 |
| 94 | MP0002419_abnormal_innate_immunity | 0.90498560 |
| 95 | MP0002452_abnormal_antigen_presenting | 0.89380268 |
| 96 | MP0004264_abnormal_extraembryonic_tissu | 0.86656843 |
| 97 | MP0001800_abnormal_humoral_immune | 0.86466002 |
| 98 | MP0001915_intracranial_hemorrhage | 0.85912181 |
| 99 | MP0000703_abnormal_thymus_morphology | 0.85550379 |
| 100 | MP0003075_altered_response_to | 0.85320406 |
| 101 | MP0002128_abnormal_blood_circulation | 0.83495358 |
| 102 | MP0003724_increased_susceptibility_to | 0.82712962 |
| 103 | MP0002429_abnormal_blood_cell | 0.82053174 |
| 104 | MP0000598_abnormal_liver_morphology | 0.81952995 |
| 105 | MP0002089_abnormal_postnatal_growth/wei | 0.81557864 |
| 106 | MP0001243_abnormal_dermal_layer | 0.81415836 |
| 107 | MP0009785_altered_susceptibility_to | 0.81162505 |
| 108 | MP0004084_abnormal_cardiac_muscle | 0.79641670 |
| 109 | MP0000249_abnormal_blood_vessel | 0.79491005 |
| 110 | MP0010307_abnormal_tumor_latency | 0.79392775 |
| 111 | MP0001845_abnormal_inflammatory_respons | 0.79035231 |
| 112 | MP0002796_impaired_skin_barrier | 0.78388582 |
| 113 | MP0002722_abnormal_immune_system | 0.78386261 |
| 114 | MP0004381_abnormal_hair_follicle | 0.77919867 |
| 115 | MP0002405_respiratory_system_inflammati | 0.77436678 |
| 116 | MP0005501_abnormal_skin_physiology | 0.76499945 |
| 117 | MP0009384_cardiac_valve_regurgitation | 0.76471641 |
| 118 | MP0005670_abnormal_white_adipose | 0.76114439 |
| 119 | MP0002249_abnormal_larynx_morphology | 0.75974240 |
| 120 | MP0001873_stomach_inflammation | 0.75552478 |
| 121 | MP0001819_abnormal_immune_cell | 0.75006467 |
| 122 | MP0009931_abnormal_skin_appearance | 0.74793009 |
| 123 | MP0002420_abnormal_adaptive_immunity | 0.74704646 |
| 124 | MP0002723_abnormal_immune_serum | 0.74118527 |
| 125 | MP0005390_skeleton_phenotype | 0.72856679 |
| 126 | MP0003866_abnormal_defecation | 0.71537036 |
| 127 | MP0002896_abnormal_bone_mineralization | 0.71395245 |
| 128 | MP0000759_abnormal_skeletal_muscle | 0.71359834 |
| 129 | MP0001614_abnormal_blood_vessel | 0.70446755 |
| 130 | MP0010329_abnormal_lipoprotein_level | 0.70192193 |
| 131 | MP0009333_abnormal_splenocyte_physiolog | 0.69849855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral aneurysm (HP:0004944) | 4.24245456 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.13731724 |
| 3 | Protrusio acetabuli (HP:0003179) | 4.10272760 |
| 4 | Peritonitis (HP:0002586) | 3.24730196 |
| 5 | Aortic aneurysm (HP:0004942) | 3.02540409 |
| 6 | Shallow orbits (HP:0000586) | 2.99742671 |
| 7 | Mitral valve prolapse (HP:0001634) | 2.97890492 |
| 8 | Myocardial infarction (HP:0001658) | 2.92771479 |
| 9 | Hyperacusis (HP:0010780) | 2.88784497 |
| 10 | Increased connective tissue (HP:0009025) | 2.80675615 |
| 11 | Aortic dissection (HP:0002647) | 2.80435174 |
| 12 | Achilles tendon contracture (HP:0001771) | 2.77685442 |
| 13 | Aneurysm (HP:0002617) | 2.73505717 |
| 14 | Abnormality of the Achilles tendon (HP:0005109) | 2.72519681 |
| 15 | Broad face (HP:0000283) | 2.64893992 |
| 16 | Ulnar bowing (HP:0003031) | 2.62347450 |
| 17 | Abnormality of the nasal mucosa (HP:0000433) | 2.61107590 |
| 18 | Upper limb amyotrophy (HP:0009129) | 2.57057155 |
| 19 | Distal upper limb amyotrophy (HP:0007149) | 2.57057155 |
| 20 | Bladder diverticulum (HP:0000015) | 2.50190350 |
| 21 | Deep venous thrombosis (HP:0002625) | 2.49491063 |
| 22 | Broad metatarsal (HP:0001783) | 2.46221725 |
| 23 | Asymmetric septal hypertrophy (HP:0001670) | 2.45893241 |
| 24 | Dilatation of the ascending aorta (HP:0005111) | 2.43321328 |
| 25 | Nasal polyposis (HP:0100582) | 2.41297982 |
| 26 | Fragile skin (HP:0001030) | 2.37944534 |
| 27 | Abnormality of macrophages (HP:0004311) | 2.37749891 |
| 28 | Increased cerebral lipofuscin (HP:0011813) | 2.36246827 |
| 29 | Difficulty climbing stairs (HP:0003551) | 2.36043497 |
| 30 | Obstructive sleep apnea (HP:0002870) | 2.32275103 |
| 31 | Type 1 muscle fiber predominance (HP:0003803) | 2.30829179 |
| 32 | Flat acetabular roof (HP:0003180) | 2.27115655 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 2.25027096 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.25027096 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.25027096 |
| 36 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.24830715 |
| 37 | Increased variability in muscle fiber diameter (HP:0003557) | 2.22794450 |
| 38 | Impaired platelet aggregation (HP:0003540) | 2.22435045 |
| 39 | Abnormal platelet function (HP:0011869) | 2.22435045 |
| 40 | Bowing of the arm (HP:0006488) | 2.20988511 |
| 41 | Bowed forearm bones (HP:0003956) | 2.20988511 |
| 42 | Xanthomatosis (HP:0000991) | 2.19267508 |
| 43 | Ankle contracture (HP:0006466) | 2.18457000 |
| 44 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.18320951 |
| 45 | Thin bony cortex (HP:0002753) | 2.18292866 |
| 46 | Atrophic scars (HP:0001075) | 2.17897881 |
| 47 | Hand muscle atrophy (HP:0009130) | 2.16768363 |
| 48 | Radial bowing (HP:0002986) | 2.15421173 |
| 49 | Hemorrhage of the eye (HP:0011885) | 2.11788283 |
| 50 | Lymphangioma (HP:0100764) | 2.11171103 |
| 51 | Cerebral inclusion bodies (HP:0100314) | 2.10747570 |
| 52 | Recurrent abscess formation (HP:0002722) | 2.10745280 |
| 53 | Neurofibrillary tangles (HP:0002185) | 2.10571514 |
| 54 | Increased density of long bones (HP:0006392) | 2.10050302 |
| 55 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.09643880 |
| 56 | Recurrent bacterial skin infections (HP:0005406) | 2.07118070 |
| 57 | Hematochezia (HP:0002573) | 2.06020529 |
| 58 | Colitis (HP:0002583) | 2.04459223 |
| 59 | Eczematoid dermatitis (HP:0000976) | 2.03368267 |
| 60 | Difficulty running (HP:0009046) | 2.02983180 |
| 61 | Genu recurvatum (HP:0002816) | 2.02714686 |
| 62 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.01901285 |
| 63 | Abnormality of the peritoneum (HP:0002585) | 2.00957843 |
| 64 | Gingivitis (HP:0000230) | 2.00276566 |
| 65 | Hyporeflexia of lower limbs (HP:0002600) | 1.99046937 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 1.98920413 |
| 67 | Disproportionate tall stature (HP:0001519) | 1.97857710 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97431134 |
| 69 | Polycythemia (HP:0001901) | 1.97294971 |
| 70 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.95605640 |
| 71 | Mediastinal lymphadenopathy (HP:0100721) | 1.94932687 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.94484429 |
| 73 | Bowel diverticulosis (HP:0005222) | 1.92983135 |
| 74 | Turricephaly (HP:0000262) | 1.92494556 |
| 75 | Right ventricular cardiomyopathy (HP:0011663) | 1.91339911 |
| 76 | Arterial tortuosity (HP:0005116) | 1.91291392 |
| 77 | Menorrhagia (HP:0000132) | 1.89334052 |
| 78 | Increased IgE level (HP:0003212) | 1.89109962 |
| 79 | Blue sclerae (HP:0000592) | 1.88431135 |
| 80 | Round ear (HP:0100830) | 1.88151069 |
| 81 | Distal lower limb muscle weakness (HP:0009053) | 1.87558698 |
| 82 | Abnormal platelet volume (HP:0011876) | 1.87153840 |
| 83 | Spontaneous hematomas (HP:0007420) | 1.87068406 |
| 84 | Osteolytic defects of the hand bones (HP:0009699) | 1.86852629 |
| 85 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.86852629 |
| 86 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.86823464 |
| 87 | Increased mean platelet volume (HP:0011877) | 1.86325527 |
| 88 | Long toe (HP:0010511) | 1.84894731 |
| 89 | Cervical subluxation (HP:0003308) | 1.84668349 |
| 90 | Subacute progressive viral hepatitis (HP:0006572) | 1.83243238 |
| 91 | Loss of speech (HP:0002371) | 1.82888537 |
| 92 | Biconcave vertebral bodies (HP:0004586) | 1.82821864 |
| 93 | Gastrointestinal inflammation (HP:0004386) | 1.82566194 |
| 94 | Hallux valgus (HP:0001822) | 1.82466280 |
| 95 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.82464268 |
| 96 | Spinal cord lesions (HP:0100561) | 1.82084434 |
| 97 | Syringomyelia (HP:0003396) | 1.82084434 |
| 98 | Camptodactyly of toe (HP:0001836) | 1.82058739 |
| 99 | Abnormality of the thoracic spine (HP:0100711) | 1.81976899 |
| 100 | Systemic lupus erythematosus (HP:0002725) | 1.81524737 |
| 101 | Vascular tortuosity (HP:0004948) | 1.80795159 |
| 102 | Thrombocytosis (HP:0001894) | 1.80640711 |
| 103 | Renal duplication (HP:0000075) | 1.80394938 |
| 104 | Distal lower limb amyotrophy (HP:0008944) | 1.79711371 |
| 105 | Back pain (HP:0003418) | 1.78989553 |
| 106 | Scapular winging (HP:0003691) | 1.78980007 |
| 107 | Polygenic inheritance (HP:0010982) | 1.78792932 |
| 108 | Metaphyseal cupping (HP:0003021) | 1.78758415 |
| 109 | Renovascular hypertension (HP:0100817) | 1.78667802 |
| 110 | Generalized amyotrophy (HP:0003700) | 1.78511978 |
| 111 | Deviation of the hallux (HP:0010051) | 1.78387171 |
| 112 | Hypercortisolism (HP:0001578) | 1.77229505 |
| 113 | Mucopolysacchariduria (HP:0008155) | 1.76824642 |
| 114 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.76824642 |
| 115 | Striae distensae (HP:0001065) | 1.76471041 |
| 116 | Neuronal loss in central nervous system (HP:0002529) | 1.75979230 |
| 117 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.75508848 |
| 118 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.75508848 |
| 119 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.75508848 |
| 120 | Persistence of primary teeth (HP:0006335) | 1.74934266 |
| 121 | Elfin facies (HP:0004428) | 1.74744874 |
| 122 | Cellulitis (HP:0100658) | 1.74374889 |
| 123 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.73801265 |
| 124 | Emphysema (HP:0002097) | 1.73229182 |
| 125 | Inflammation of the large intestine (HP:0002037) | 1.73022593 |
| 126 | Short nail (HP:0001799) | 1.73009345 |
| 127 | Ectopia lentis (HP:0001083) | 1.72939489 |
| 128 | Myositis (HP:0100614) | 1.72345011 |
| 129 | Long palpebral fissure (HP:0000637) | 1.72151798 |
| 130 | Insomnia (HP:0100785) | 1.71780682 |
| 131 | Obstructive lung disease (HP:0006536) | 1.71704083 |
| 132 | Chronic obstructive pulmonary disease (HP:0006510) | 1.71704083 |
| 133 | Nephritis (HP:0000123) | 1.71319953 |
| 134 | Spinal rigidity (HP:0003306) | 1.70854590 |
| 135 | Dysostosis multiplex (HP:0000943) | 1.69224723 |
| 136 | Amyloidosis (HP:0011034) | 1.68763847 |
| 137 | Vertebral compression fractures (HP:0002953) | 1.67784464 |
| 138 | Abnormality of complement system (HP:0005339) | 1.67605705 |
| 139 | Mitral regurgitation (HP:0001653) | 1.67505798 |
| 140 | Rectal prolapse (HP:0002035) | 1.66572907 |
| 141 | Wormian bones (HP:0002645) | 1.66047046 |
| 142 | Bone pain (HP:0002653) | 1.65558561 |
| 143 | Limb-girdle muscle atrophy (HP:0003797) | 1.64176746 |
| 144 | Arnold-Chiari malformation (HP:0002308) | 1.63771649 |
| 145 | Abnormality of the fingertips (HP:0001211) | 1.63749028 |
| 146 | Thoracic kyphosis (HP:0002942) | 1.62421725 |
| 147 | Abnormal ossification of hand bones (HP:0005921) | 1.58336895 |
| 148 | Premature skin wrinkling (HP:0100678) | 1.57752806 |
| 149 | Nuclear cataract (HP:0100018) | 1.56659646 |
| 150 | Orchitis (HP:0100796) | 1.56286896 |
| 151 | J-shaped sella turcica (HP:0002680) | 1.55292892 |
| 152 | Spondylolisthesis (HP:0003302) | 1.53798039 |
| 153 | Purpura (HP:0000979) | 1.53787612 |
| 154 | Supranuclear gaze palsy (HP:0000605) | 1.53211093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.36543774 |
| 2 | PKN2 | 4.11706511 |
| 3 | ERN1 | 3.41349621 |
| 4 | PRPF4B | 3.24748430 |
| 5 | EEF2K | 3.12900482 |
| 6 | SMG1 | 2.75780873 |
| 7 | TTN | 2.52743744 |
| 8 | MAP3K10 | 2.49241276 |
| 9 | PTK6 | 2.27312433 |
| 10 | MAP4K1 | 1.89758256 |
| 11 | RIPK1 | 1.86646646 |
| 12 | LRRK2 | 1.83246550 |
| 13 | SIK1 | 1.80731939 |
| 14 | ICK | 1.80637424 |
| 15 | MAP3K13 | 1.79347314 |
| 16 | EPHB1 | 1.75871223 |
| 17 | BMX | 1.68470152 |
| 18 | TGFBR2 | 1.68354026 |
| 19 | PDGFRA | 1.61951025 |
| 20 | FGFR4 | 1.61172836 |
| 21 | TBK1 | 1.60018041 |
| 22 | BLK | 1.50818388 |
| 23 | TYK2 | 1.40389317 |
| 24 | IRAK4 | 1.38115111 |
| 25 | DDR2 | 1.34427832 |
| 26 | PAK4 | 1.31988766 |
| 27 | MAP2K3 | 1.24914078 |
| 28 | MAP3K7 | 1.24553567 |
| 29 | TAOK2 | 1.24180762 |
| 30 | MAP3K1 | 1.22445259 |
| 31 | DMPK | 1.21223352 |
| 32 | EPHA2 | 1.21212380 |
| 33 | SCYL2 | 1.21071676 |
| 34 | CDC42BPA | 1.19864585 |
| 35 | JAK1 | 1.17142803 |
| 36 | PTK2 | 1.16997612 |
| 37 | DYRK1B | 1.16107644 |
| 38 | RIPK4 | 1.16056188 |
| 39 | SIK2 | 1.12881991 |
| 40 | MAP3K14 | 1.12678778 |
| 41 | CSK | 1.12587746 |
| 42 | ZAP70 | 1.12334958 |
| 43 | CDK12 | 1.09547979 |
| 44 | FLT3 | 1.07192398 |
| 45 | KSR2 | 1.06251836 |
| 46 | CSF1R | 0.99632554 |
| 47 | MAP3K6 | 0.99027821 |
| 48 | TAOK1 | 0.98149584 |
| 49 | GRK6 | 0.94801972 |
| 50 | TAOK3 | 0.94635359 |
| 51 | MTOR | 0.93411407 |
| 52 | ALK | 0.93018641 |
| 53 | ILK | 0.91904145 |
| 54 | JAK3 | 0.90648528 |
| 55 | PAK2 | 0.89449973 |
| 56 | HIPK2 | 0.88548569 |
| 57 | CDK6 | 0.86206830 |
| 58 | HCK | 0.84005164 |
| 59 | PRKD2 | 0.82647960 |
| 60 | STK10 | 0.79459460 |
| 61 | RET | 0.78852854 |
| 62 | FGFR3 | 0.76293027 |
| 63 | JAK2 | 0.76150151 |
| 64 | EPHB2 | 0.75981963 |
| 65 | IKBKE | 0.75937792 |
| 66 | CAMK1D | 0.74669126 |
| 67 | ARAF | 0.74606507 |
| 68 | IRAK2 | 0.74025130 |
| 69 | FER | 0.73478551 |
| 70 | TYRO3 | 0.72688366 |
| 71 | BTK | 0.70673506 |
| 72 | MST1R | 0.70470445 |
| 73 | MAP2K2 | 0.69902335 |
| 74 | MARK2 | 0.68927702 |
| 75 | NTRK1 | 0.68358046 |
| 76 | PRKD1 | 0.67688510 |
| 77 | NEK9 | 0.67595218 |
| 78 | PDGFRB | 0.66694652 |
| 79 | KIT | 0.65932781 |
| 80 | RPS6KA4 | 0.65400596 |
| 81 | PDPK1 | 0.65198322 |
| 82 | IRAK3 | 0.65170895 |
| 83 | CAMK1G | 0.65014806 |
| 84 | MAPKAPK3 | 0.64870046 |
| 85 | MAP3K11 | 0.64236981 |
| 86 | FES | 0.63750152 |
| 87 | IKBKB | 0.62186533 |
| 88 | EPHA3 | 0.61045695 |
| 89 | MAPK12 | 0.61007743 |
| 90 | PDK1 | 0.59898197 |
| 91 | KDR | 0.58806611 |
| 92 | MAPK11 | 0.58775181 |
| 93 | MATK | 0.57486711 |
| 94 | TESK2 | 0.57076142 |
| 95 | PRKG2 | 0.56946164 |
| 96 | MOS | 0.56871339 |
| 97 | TLK1 | 0.56116794 |
| 98 | STK38 | 0.55483742 |
| 99 | MAP3K3 | 0.55404474 |
| 100 | CHUK | 0.54470878 |
| 101 | RPS6KB2 | 0.54397546 |
| 102 | DAPK3 | 0.53989334 |
| 103 | SGK3 | 0.53838136 |
| 104 | TESK1 | 0.53589938 |
| 105 | SIK3 | 0.52961067 |
| 106 | PIM1 | 0.51878490 |
| 107 | RPS6KA6 | 0.51650962 |
| 108 | BCKDK | 0.49800881 |
| 109 | FGR | 0.49396411 |
| 110 | RPS6KA2 | 0.49339120 |
| 111 | PRKCH | 0.48881385 |
| 112 | NME2 | 0.48406464 |
| 113 | GSK3A | 0.48257543 |
| 114 | MAP3K8 | 0.47327086 |
| 115 | LATS2 | 0.46776154 |
| 116 | CDK4 | 0.46564502 |
| 117 | RPS6KC1 | 0.46292972 |
| 118 | RPS6KL1 | 0.46292972 |
| 119 | TNK2 | 0.45362545 |
| 120 | CAMKK1 | 0.43182831 |
| 121 | PRKAA2 | 0.42673863 |
| 122 | ITK | 0.42556979 |
| 123 | PIM2 | 0.42082195 |
| 124 | MAPK7 | 0.41265013 |
| 125 | RPS6KA1 | 0.40932181 |
| 126 | LCK | 0.40750306 |
| 127 | TRPM7 | 0.40517923 |
| 128 | LMTK2 | 0.40395505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.25241254 |
| 2 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.95527409 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79782340 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.77293387 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.63778290 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.60122959 |
| 7 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.57532938 |
| 8 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.57208609 |
| 9 | Insulin resistance_Homo sapiens_hsa04931 | 1.56426811 |
| 10 | Focal adhesion_Homo sapiens_hsa04510 | 1.53350034 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.50990955 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48162149 |
| 13 | Bladder cancer_Homo sapiens_hsa05219 | 1.44633708 |
| 14 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.40830148 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39905975 |
| 16 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.37005067 |
| 17 | Amoebiasis_Homo sapiens_hsa05146 | 1.36398151 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.34300300 |
| 19 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.34189688 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31747654 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.30134253 |
| 22 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.27234674 |
| 23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26401546 |
| 24 | Platelet activation_Homo sapiens_hsa04611 | 1.25833493 |
| 25 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.24388884 |
| 26 | Lysine degradation_Homo sapiens_hsa00310 | 1.22417389 |
| 27 | Prion diseases_Homo sapiens_hsa05020 | 1.19565594 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.19516388 |
| 29 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.18689125 |
| 30 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.18522554 |
| 31 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.15186529 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13289807 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11439509 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11239843 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10179799 |
| 36 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.10078391 |
| 37 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.09735432 |
| 38 | Galactose metabolism_Homo sapiens_hsa00052 | 1.08465511 |
| 39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.07259302 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.06682478 |
| 41 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.06273543 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.04966354 |
| 43 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03150243 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.02644085 |
| 45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.01672918 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01087395 |
| 47 | Colorectal cancer_Homo sapiens_hsa05210 | 1.00688913 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 1.00353083 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00317174 |
| 50 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.98638920 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98437999 |
| 52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.96134342 |
| 53 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.95255600 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95190015 |
| 55 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.95044109 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.94984284 |
| 57 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.93194717 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.92744581 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92610987 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.89846381 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.89807227 |
| 62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89755078 |
| 63 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.89547802 |
| 64 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.89139684 |
| 65 | Thyroid cancer_Homo sapiens_hsa05216 | 0.87999204 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87590232 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.87306863 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.86555643 |
| 69 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.85556204 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84315041 |
| 71 | Tuberculosis_Homo sapiens_hsa05152 | 0.83717056 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82612253 |
| 73 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.82211609 |
| 74 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.82007755 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81714574 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.81684873 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 0.81444698 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.81117132 |
| 79 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.79669048 |
| 80 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79395729 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78743471 |
| 82 | Malaria_Homo sapiens_hsa05144 | 0.77593905 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.76937543 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.76735001 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.75055206 |
| 86 | Bile secretion_Homo sapiens_hsa04976 | 0.74836401 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74034825 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.73994652 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73802725 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73359930 |
| 91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72596153 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72532978 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.70078658 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69880521 |
| 95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69401547 |
| 96 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69078756 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68437556 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67335843 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.66893006 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.66694808 |
| 101 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66416814 |
| 102 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66055441 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65226728 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64664217 |
| 105 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64335912 |
| 106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64122184 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63567605 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63449223 |
| 109 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.63381444 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.63332316 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60893317 |
| 112 | Influenza A_Homo sapiens_hsa05164 | 0.60842166 |
| 113 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60395617 |
| 114 | Phagosome_Homo sapiens_hsa04145 | 0.60277852 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60176174 |
| 116 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59842014 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59061604 |
| 118 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58441924 |
| 119 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.58034078 |
| 120 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57841136 |
| 121 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57705916 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56445047 |
| 123 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55138687 |
| 124 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.54335479 |
| 125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54308870 |
| 126 | Prostate cancer_Homo sapiens_hsa05215 | 0.53883969 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51860207 |
| 128 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.49677840 |

